In patients with advanced pulmonary arterial hypertension (PAH), the addition of the biologic sotatercept-csrk (Winrevair; Merck) to maximum tolerated background therapy reduces the risk of death more ...
State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union ...
Eli Lilly and Novo Nordisk have filed dozens of lawsuits against compounding pharmacies marketing their own versions of popular weight loss and diabetes drugs. A … ...
WASHINGTON, Nov 20 (Reuters) - U.S. House Speaker Mike Johnson said on Wednesday that all single-sex bathrooms in the U.S. Capitol building would be reserved for "individuals of that biological ...